세계의 분자 품질관리 시장 예측(-2028년) : 제품 유형별, 용도별, 검체 유형별, 최종사용자별, 지역별

Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control ), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028

US $ 4,950 ￦ 6,884,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,248,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,335,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,908,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 분자 품질관리 시장 규모는 2023년 2억 달러에서 2028년까지 3억 달러에 달하며, 예측 기간 중 CAGR로 6.6%의 성장이 예측됩니다.

시장의 성장은 주로 게놈 프로젝트에 대한 정부의 자금 제공 증가 및 맞춤형 의료에 대한 수요의 증가, 시퀀싱 시술의 비용 하락, 감염증, 암, 유전성 질환의 유행에 의해 촉진되고 있습니다. 그러나 품질관리 프로세스에 수반하는 추가 비용 및 병원과 연구소에서의 예산 제약, 분자 검사에 대한 불리한 상환 시나리오가 예측 기간 중 시장 성장을 억제할 것으로 전망되는 주요 요인입니다.

독립 관리 부문이 예측 기간 중 시장에서 최대 점유율을 차지할 전망입니다.

제품별로 시장은 독립 관리와 기구 고유 관리로 구분됩니다. 2022년 세계의 분자 품질관리 시장에서는 독립 관리 부문이 최대 점유율을 차지하고 있습니다. 서드파티 독립 관리의 이용 증가가 이 부문의 큰 점유율 요인입니다.

단일 검체 관리가 예측 기간 중 시장에서 최대 점유율을 차지할 전망입니다.

검체 유형별로 시장은 단일 검체 관리와 복수 검체 관리로 구분됩니다. 단일 검체 관리는 2022년 분자 품질관리 시장에서 최대 점유율을 차지했습니다. 병원에서 싱글플렉스 어세이의 현저한 이용 및 낮은 교차 반응성의 리스크 등이 이 부문의 큰 점유율 요인입니다.

감염증 진단 부문이 2022년에 시장에서 최대 점유율을 차지했습니다.

용도별로 시장은 감염증 진단, 유전자 검사, 종양 검사, 기타 용도(신경질환 검사, DNA 핑거 프린팅, 조직 타이핑, 미생물학, 심혈관질환 검사 포함)로 구분됩니다. 감염증 진단 부문은 2022년 세계의 분자 품질관리 시장에서 최대 점유율을 차지했습니다. 감염증의 유병률 대폭적인 증가가 이 부문 큰 점유율 요인입니다.

진단 연구소 부문은 2022년에 시장에서 최대 점유율을 차지했습니다.

최종사용자별로 시장은 학술·연구기관, 진단 연구소, IVD 제조업체·CRO, 병원, 기타 최종사용자(재택의료 기관, 혈액은행, 너싱홈, 지역의 공중보건 연구소)로 구분됩니다. 진단 연구소 부문이 2022년에 분자 품질관리 시장에서 최대 점유율을 차지했습니다. 진단 연구소에서 시행되는 임상 검사 수의 증가가 이 부문의 큰 점유율 요인입니다.

북미가 2022년 분자 품질관리 시장에서 최대 점유율을 차지했습니다.

지역별로 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 구분됩니다. 북미는 2022년에 분자 품질관리 시장을 독점했습니다. 이 지역 부문이 큰 점유율을 차지하고 있는 것은 주로 미국과 캐나다에서 의료 시스템이 발달하고 있는 것 및 분자 품질관리 제품의 주요 제조업체가 다수 존재하는 것, 북미에서 첨단 기술 제품이 용이하게 이용할 수 있는 것 등에 기인합니다.

세계의 분자 품질관리 시장에 대해 조사분석했으며, 시장 역학, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

• 분자 품질관리 시장의 개요
• 분자 품질관리 시장 : 제품별
• 아시아태평양, 분자 품질관리 시장 : 용도별, 국가별
• 분자 품질관리 시장 : 지역적 믹스
• 분자 품질관리 시장 : 선진국 시장 vs. 신흥 시장

제5장 시장의 개요

• 서론
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 업계의 동향
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 에코시스템 분석
• Porter's Five Forces 분석
• 무역 분석
• 관세와 규제 분석
• 특허 분석
• 주요 컨퍼런스와 이벤트
• 주요 이해관계자와 구입 기준
• 고객의 비즈니스에 영향을 미치는 동향과 혼란

제6장 분자 품질관리 시장 : 제품별

• 서론
• 독립 관리
• 기구 고유 관리
  • 중합효소 연쇄 반응
  • DNA 시퀀싱, NGS
  • 기타 기술

제7장 분자 품질관리 시장 : 검체 유형별

• 서론
• 단일 검체 관리
• 복수 검체 관리

제8장 분자 품질관리 시장 : 용도별

• 서론
• 감염증 진단
• 종양 검사
• 유전자 검사
• 기타 용도

제9장 분자 품질관리 시장 : 최종사용자별

• 서론
• 진단 연구소
• 병원
• IVD 제조업체·CRO
• 학술·연구기관
• 기타 최종사용자

제10장 분자 품질관리 시장 : 지역별

• 서론
• 북미
  • 미국
  • 캐나다
  • 북미 : 불황의 영향
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 러시아
  • 기타 유럽
  • 유럽 : 불황의 영향
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 기타 아시아태평양
  • 아시아태평양 : 불황의 영향
• 라틴아메리카
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 라틴아메리카 : 불황의 영향
• 중동 및 아프리카

제11장 경쟁 구도

• 개요
• 주요 기업이 채택한 전략
• 주요 시장 기업의 매출 점유율 분석
• 시장 점유율 분석
• 주요 기업의 기업 평가 매트릭스(2022년)
• 스타트업/중소기업 기업 평가 매트릭스(2022년)
• 기업 발자국 분석
• 경쟁 상황과 동향

제12장 기업 개요

• 주요 기업
  • LGC LIMITED
  • THERMO FISHER SCIENTIFIC, INC.
  • BIO-RAD LABORATORIES, INC.
  • MICROBIOLOGICS, INC.
  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE LTD.
  • ZEPTOMETRIX, LLC
  • QUIDELORTHO CORPORATION
  • QNOSTICS
  • MAINE MOLECULAR QUALITY CONTROLS, INC.
  • RANDOX LABORATORIES LTD.
  • DANAHER CORPORATION
  • BIO-TECHNE CORPORATION
  • FORTRESS DIAGNOSTICS
  • MICROBIX BIOSYSTEMS
  • GRIFOLS, S.A.
  • ANCHOR MOLECULAR
  • SPEEDX PTY. LTD.
  • SEEGENE INC.
  • HELENA LABORATORIES CORPORATION
• 기타 기업
  • SERO AS
  • VIRCELL, S.L.
  • STRECK LLC
  • SUN DIAGNOSTICS, LLC
  • MOLBIO DIAGNOSTICS PVT. LTD.

제13장 부록

KSA

영문 목차

영문목차

The global molecular quality controls market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 6.6% during the forecast period. Growth in this market is primarily driven by the increasing government funding for genomic projects, increasing demand for personalized medicines and declining costs of sequencing procedures, and increasing prevalence of infectious diseases, cancer, and genetic diseases. However, the additional costs involved in the quality control process and budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are the major factors that are expected to restrain the growth of this market during the forecast period.

The independent controls segment has accounted for the biggest share of the market during the forecast period

By product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the biggest share of the global molecular quality controls market in 2022. The increasing use of third-party independent quality controls is responsible for the large share of this segment.

The single-analyte controls has accounted for the biggest share of the market during the forecast period.

By analyte type, the molecular quality controls market is divided into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the biggest share of the molecular quality controls market in 2022. Factors such as the significant use of singleplex assays in hospitals, and low risk of cross-reactivity are responsible for the large share of this segment.

The infectious disease diagnostic segment accounted for the biggest share of the market in 2022

By application, the molecular quality controls market is divided into infectious disease diagnostics, genetic testing, oncology testing, and other applications (including neurology disease testing, , DNA fingerprinting, tissue typing, microbiology and cardiovascular disease testing). The infectious disease diagnostics segment accounted for the biggest share of the global molecular quality controls market in 2022. The significant increase in the prevalence of infectious diseases is responsible for the large share of this segment.

The diagnostic laboratories segment accounted for the biggest share of the market in 2022

By end users, the molecular quality controls market is segmented into academic & research institutes, diagnostic laboratories, IVD manufacturers & CROs, hospitals and other end users (home health agencies, blood banks, nursing homes, and local public health laboratories). The diagnostic laboratories segment accounted for the biggest share of the molecular quality controls market in 2022. The growing number of laboratory tests performed in diagnostic laboratories is responsible for the large share of this segment.

North America accounted for the largest share of the Molecular Quality Controls market in 2022

Based on region, the molecular quality controls market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the molecular quality controls market in 2022. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.

The break up of the profile of primary participants in the molecular Quality controls market:

• By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
• By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
• By Region: North America - 40%, Europe - 30%, APAC -20%, Latin America - 5%,Middle East & Africa-5%

Key players in the molecular quality controls market

The key players operating in the molecular quality controls market include Microbiologics, Inc. (US), Steck, Inc. (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Helena Laboratories Corporation (US), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

Research Coverage:

The report analyzes the molecular quality controls market and aims at estimating the market size and future growth potential of this market based on various segments such as product, analyte type, application, and end user. The report also includes a product portfolio matrix of various molecular quality controls products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

• Analysis of key drivers (growing adoption of third-party quality controls, increasing investments in genomics, growing preference for personalized medicines, rising demand for external quality assessment support, and increasing prevalence of infectious diseases and cancer), restraints (high costs and budget constraints in clinical laboratories, and unfavorable reimbursement for molecular tests), opportunities (rising demand for multi-analyte controls, and growth opportunities in emerging countries), and challenges (changing regulatory framework)
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global molecular quality controls market
• Market Development: Comprehensive information on the lucrative emerging markets by product, analyte type, application, and end user.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global molecular quality controls market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global molecular quality controls market. This report also helps stakeholders understand the pulse of the molecular quality controls market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
• 1.5 STUDY LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
• 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
  • FIGURE 2 PRIMARY SOURCES
    • 2.2.2.1 Key data from primary sources
  • FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS
    • 2.2.2.2 Breakdown of primaries
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.3 MARKET SIZE ESTIMATION
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS
  • FIGURE 7 MARKET SIZE ESTIMATION: PARENT MARKET
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 MOLECULAR QUALITY CONTROLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
• 2.5 MARKET SHARE ANALYSIS
• 2.6 STUDY ASSUMPTIONS
• 2.7 RISK ASSESSMENT
  • TABLE 2 MOLECULAR QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS
• 2.8 MARKET LIMITATIONS
  • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8.2 SCOPE-RELATED LIMITATIONS
• 2.9 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 11 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 14 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MOLECULAR QUALITY CONTROLS MARKET

4 PREMIUM INSIGHTS

• 4.1 MOLECULAR QUALITY CONTROLS MARKET OVERVIEW
  • FIGURE 16 RISING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE MARKET
• 4.2 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
  • FIGURE 17 INSTRUMENT-SPECIFIC CONTROLS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.3 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION AND COUNTRY
  • FIGURE 18 INFECTIOUS DISEASE DIAGNOSTICS SEGMENT IN JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.4 MOLECULAR QUALITY CONTROLS MARKET: GEOGRAPHICAL MIX
  • FIGURE 19 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• 4.5 MOLECULAR QUALITY CONTROLS MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS
  • FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
  • FIGURE 21 MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.1.1 DRIVERS
    • 5.1.1.1 Rising number of accredited clinical laboratories
  • FIGURE 22 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
    • 5.1.1.2 Growing adoption of third-party quality controls
  • TABLE 3 THIRD-PARTY INDEPENDENT QUALITY CONTROLS OFFERED BY KEY COMPANIES
    • 5.1.1.3 Increasing investments in genomics
  • TABLE 4 GOVERNMENT FUNDING INITIATIVES FOR GENOMICS RESEARCH (2019-2022)
    • 5.1.1.4 Growing preference for personalized medicine
  • TABLE 5 US: NUMBER OF PERSONALIZED MEDICINES AVAILABLE (2008-2020)
  • FIGURE 23 FDA-APPROVED PERSONALIZED MEDICINES (2015-2022)
  • FIGURE 24 COST OF SEQUENCING PROCEDURES (2016-2021)
    • 5.1.1.5 Increasing prevalence of infectious diseases and cancer
  • FIGURE 25 GLOBAL CANCER INCIDENCE, 2018-2040 (MILLION)
    • 5.1.1.6 Rising demand for external quality assessment support
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 Budgetary constraints in clinical laboratories
    • 5.1.2.2 Unfavorable reimbursements for molecular tests
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Rising demand for multi-analyte controls
    • 5.1.3.2 Growth opportunities in emerging markets
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Stringent regulatory requirements for IVD products
• 5.2 INDUSTRY TRENDS
  • 5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
  • TABLE 6 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY COMPANIES
• 5.3 PRICING ANALYSIS
  • TABLE 7 PRICE RANGE FOR MOLECULAR QUALITY CONTROLS, BY TYPE (2022)
• 5.4 VALUE CHAIN ANALYSIS
  • FIGURE 26 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
  • FIGURE 27 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
  • FIGURE 28 MOLECULAR QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 MOLECULAR QUALITY CONTROLS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 TRADE ANALYSIS
  • 5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC & LABORATORY REAGENTS
    • 5.8.1.1 Import data for diagnostic & laboratory reagents, by country, 2018-2021 (USD million)
    • 5.8.1.2 Export data for diagnostic & laboratory reagents, by country, 2018-2021 (USD million)
• 5.9 TARIFF AND REGULATORY ANALYSIS
  • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9.2 REGULATORY ANALYSIS
    • 5.9.2.1 North America
      • 5.9.2.1.1 US
  • TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
  • TABLE 12 US: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
    • 5.9.2.1.2 Canada
  • TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS
  • TABLE 14 CANADA: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
    • 5.9.2.2 Europe
  • TABLE 15 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
    • 5.9.2.3 Asia Pacific
      • 5.9.2.3.1 Japan
      • 5.9.2.3.2 China
      • 5.9.2.3.3 India
• 5.10 PATENT ANALYSIS
  • 5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • FIGURE 29 MOLECULAR QUALITY CONTROLS MARKET: TOP PATENT OWNERS AND APPLICANTS (JANUARY 2011-JUNE 2023)
  • FIGURE 30 MOLECULAR QUALITY CONTROLS MARKET: TOP APPLICANT JURISDICTIONS (JANUARY 2011-JUNE 2023)
  • 5.10.2 PATENT PUBLICATION TRENDS
  • FIGURE 31 MOLECULAR QUALITY CONTROLS MARKET: PATENT ANALYSIS (JANUARY 2011-FEBRUARY 2023)
  • TABLE 16 MOLECULAR QUALITY CONTROLS MARKET: LIST OF PATENTS/PATENT APPLICATIONS (2020-2023)
• 5.11 KEY CONFERENCES AND EVENTS
  • TABLE 17 MOLECULAR QUALITY CONTROLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023-2024
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS (%)
  • 5.12.2 BUYING CRITERIA
  • FIGURE 33 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
  • TABLE 19 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
• 5.13 TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS' BUSINESSES
  • FIGURE 34 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHIFT

6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 20 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
  • TABLE 21 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 INDEPENDENT CONTROLS
  • 6.2.1 MINIMIZED LOT CROSSOVERS FOR LABORATORIES AND LOW OPERATION COSTS TO DRIVE MARKET
  • TABLE 22 INDEPENDENT MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 23 INDEPENDENT MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.3 INSTRUMENT-SPECIFIC CONTROLS
  • TABLE 24 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 25 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 26 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 6.3.1 POLYMERASE CHAIN REACTION
    • 6.3.1.1 Rising applications in proteomics and genomics to propel market
  • TABLE 27 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.2 DNA SEQUENCING AND NGS
    • 6.3.2.1 Increasing advancements in sequencing technologies to drive market
  • TABLE 28 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.3 OTHER TECHNOLOGIES
  • TABLE 29 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

7 MOLECULAR QUALITY CONTROL MARKET, BY ANALYTE TYPE

• 7.1 INTRODUCTION
  • TABLE 30 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
• 7.2 SINGLE-ANALYTE CONTROLS
  • 7.2.1 RISING ADOPTION OF SINGLEPLEX ASSAYS IN HOSPITALS TO SUPPORT MARKET GROWTH
  • TABLE 31 SINGLE-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 32 SINGLE-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 MULTI-ANALYTE CONTROLS
  • 7.3.1 GROWING PREFERENCE FOR COST-EFFECTIVE CONTROLS TO DRIVE MARKET
  • TABLE 33 MULTI-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
  • TABLE 34 MULTI-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 35 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.2 INFECTIOUS DISEASE DIAGNOSTICS
  • 8.2.1 RISING INCIDENCE OF INFLUENZA, TB, AND HIV TO DRIVE MARKET
  • TABLE 36 NUMBER OF COVID-19 CASES, BY COUNTRY (FEBRUARY 2023)
  • TABLE 37 MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 ONCOLOGY TESTING
  • 8.3.1 GROWING FOCUS ON PERSONALIZED MEDICINE TO PROPEL MARKET
  • TABLE 38 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
  • TABLE 39 MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 GENETIC TESTING
  • 8.4.1 ABILITY TO DIAGNOSE RARE DISEASES TO SUPPORT MARKET GROWTH
  • TABLE 40 MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.5 OTHER APPLICATIONS
  • TABLE 41 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 42 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.2 DIAGNOSTIC LABORATORIES
  • 9.2.1 INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES TO DRIVE MARKET
  • TABLE 43 MOLECULAR QUALITY CONTROLS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.3 HOSPITALS
  • 9.3.1 ABILITY TO CONDUCT LARGE VOLUME OF DIAGNOSTIC PROCEDURES TO PROPEL MARKET
  • TABLE 44 MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.4 IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
  • 9.4.1 ADVANCEMENTS IN MOLECULAR TECHNOLOGIES TO SUPPORT MARKET GROWTH
  • TABLE 45 MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.5 ACADEMIC & RESEARCH INSTITUTES
  • 9.5.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET
  • TABLE 46 MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.6 OTHER END USERS
  • TABLE 47 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 MOLECULAR QUALITY CONTROLS MARKET, BY REGION

• 10.1 INTRODUCTION
  • TABLE 48 MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 10.2 NORTH AMERICA
  • FIGURE 35 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • TABLE 49 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 50 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 54 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.1 US
    • 10.2.1.1 Growing number of accredited clinical laboratories to drive market
  • FIGURE 36 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
  • TABLE 55 US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 56 US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 57 US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 58 US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 59 US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.2 CANADA
    • 10.2.2.1 Rising funding investments for genomic research to propel market
  • TABLE 60 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 61 CANADA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 62 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 63 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 64 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.3 NORTH AMERICA: RECESSION IMPACT
• 10.3 EUROPE
  • TABLE 65 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 66 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 67 EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 68 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 69 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 70 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.1 GERMANY
    • 10.3.1.1 Rising volume of diagnostic tests in clinical settings to drive market
  • TABLE 71 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 72 GERMANY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 73 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 74 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 75 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.2 UK
    • 10.3.2.1 Growth in life sciences industry to propel market
  • TABLE 76 UK: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 77 UK: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 78 UK: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 79 UK: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 80 UK: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.3 FRANCE
    • 10.3.3.1 Rising prevalence of cancer and endocrine disorders to support market growth
  • TABLE 81 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 82 FRANCE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 83 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 84 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 85 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.4 ITALY
    • 10.3.4.1 Rising incidence of age-associated chronic ailments to support market growth
  • TABLE 86 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 87 ITALY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 88 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 89 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 90 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.5 SPAIN
    • 10.3.5.1 Increasing demand for prenatal and genetic testing to support market growth
  • TABLE 91 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 92 SPAIN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 93 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 94 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 95 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.6 RUSSIA
    • 10.3.6.1 Growing acceptance of molecular diagnostics-based personalized medicine to propel market
  • TABLE 96 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 97 RUSSIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 98 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 99 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 100 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.7 REST OF EUROPE
  • TABLE 101 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 102 REST OF EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 103 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 104 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 105 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.8 EUROPE: RECESSION IMPACT
• 10.4 ASIA PACIFIC
  • FIGURE 37 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
  • TABLE 106 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.1 JAPAN
    • 10.4.1.1 Established healthcare system and rising demand for high-quality IVD tests to drive market
  • TABLE 112 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 113 JAPAN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 114 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 115 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 116 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.2 CHINA
    • 10.4.2.1 Rising R&D investments for advanced molecular tests to drive market
  • TABLE 117 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 118 CHINA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 119 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 120 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 121 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.3 INDIA
    • 10.4.3.1 Rising need to secure NABL accreditations to support market growth
  • FIGURE 38 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS (2012-2020)
  • TABLE 122 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 123 INDIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 124 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 125 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 126 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.4 AUSTRALIA
    • 10.4.4.1 High prevalence of infectious diseases to fuel market
  • TABLE 127 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 128 AUSTRALIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 129 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 130 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 131 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.5 REST OF ASIA PACIFIC
  • TABLE 132 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 133 REST OF ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 134 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 136 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.6 ASIA PACIFIC: RECESSION IMPACT
• 10.5 LATIN AMERICA
  • TABLE 137 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 138 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 139 LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 140 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 141 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 142 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, ' 2021-2028 (USD MILLION)
  • 10.5.1 BRAZIL
    • 10.5.1.1 Improving healthcare infrastructure to support market growth
  • TABLE 143 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 144 BRAZIL: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 145 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 146 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 147 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.2 MEXICO
    • 10.5.2.1 Improving accessibility and affordability of healthcare services to support market growth
  • TABLE 148 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 149 MEXICO: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 150 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 151 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 152 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.3 REST OF LATIN AMERICA
  • TABLE 153 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 154 REST OF LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 155 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 156 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 157 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.4 LATIN AMERICA: RECESSION IMPACT
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
  • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 158 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 159 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 160 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • TABLE 161 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 162 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
• 11.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
  • FIGURE 39 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS OF LEADING PLAYERS
• 11.4 MARKET SHARE ANALYSIS
  • FIGURE 40 MOLECULAR QUALITY CONTROLS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
  • TABLE 163 MOLECULAR QUALITY CONTROLS MARKET: INTENSITY OF COMPETITIVE RIVALRY
• 11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • FIGURE 41 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
• 11.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 STARTING BLOCKS
  • 11.6.3 RESPONSIVE COMPANIES
  • 11.6.4 DYNAMIC COMPANIES
  • FIGURE 42 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
• 11.7 COMPANY FOOTPRINT ANALYSIS
  • TABLE 164 MOLECULAR QUALITY CONTROLS MARKET: COMPANY FOOTPRINT ANALYSIS
  • TABLE 165 MOLECULAR QUALITY CONTROLS MARKET: ANALYTE TYPE FOOTPRINT ANALYSIS
  • TABLE 166 MOLECULAR QUALITY CONTROLS MARKET: APPLICATION FOOTPRINT ANALYSIS
  • TABLE 167 MOLECULAR QUALITY CONTROLS MARKET: REGIONAL FOOTPRINT ANALYSIS
  • TABLE 168 MOLECULAR QUALITY CONTROLS MARKET: END USER FOOTPRINT ANALYSIS
• 11.8 COMPETITIVE SITUATION AND TRENDS
  • 11.8.1 PRODUCT LAUNCHES & APPROVALS
  • TABLE 169 PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-JUNE 2023)
  • 11.8.2 DEALS
  • TABLE 170 DEALS (JANUARY 2020-JUNE 2023)
  • 11.8.3 OTHER DEVELOPMENTS
  • TABLE 171 OTHER DEVELOPMENTS (JANUARY 2020-JUNE 2023)

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
• (Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)**
• 12.1.1 LGC LIMITED
• TABLE 172 LGC LIMITED: BUSINESS OVERVIEW
• FIGURE 43 LCG LIMITED: COMPANY SNAPSHOT (2022)
• 12.1.2 THERMO FISHER SCIENTIFIC, INC.
• TABLE 173 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
• FIGURE 44 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
• 12.1.3 BIO-RAD LABORATORIES, INC.
• TABLE 174 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
• FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
• 12.1.4 MICROBIOLOGICS, INC.
• TABLE 175 MICROBIOLOGICS, INC.: BUSINESS OVERVIEW
• 12.1.5 ABBOTT LABORATORIES
• TABLE 176 ABBOTT LABORATORIES: BUSINESS OVERVIEW
• FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
• 12.1.6 F. HOFFMANN-LA ROCHE LTD.
• TABLE 177 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
• FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
• 12.1.7 ZEPTOMETRIX, LLC
• TABLE 178 ZEPTOMETRIX, LLC: BUSINESS OVERVIEW
• 12.1.8 QUIDELORTHO CORPORATION
• TABLE 179 QUIDELORTHO CORPORATION: BUSINESS OVERVIEW
• FIGURE 48 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.9 QNOSTICS
• TABLE 180 QNOSTICS: BUSINESS OVERVIEW
• 12.1.10 MAINE MOLECULAR QUALITY CONTROLS, INC.
• TABLE 181 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
• 12.1.11 RANDOX LABORATORIES LTD.
• TABLE 182 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
• 12.1.12 DANAHER CORPORATION
• TABLE 183 DANAHER CORPORATION: BUSINESS OVERVIEW
• FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.13 BIO-TECHNE CORPORATION
• TABLE 184 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
• FIGURE 50 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.14 FORTRESS DIAGNOSTICS
• TABLE 185 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
• 12.1.15 MICROBIX BIOSYSTEMS
• TABLE 186 MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW
• FIGURE 51 MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT (2022)
• 12.1.16 GRIFOLS, S.A.
• TABLE 187 GRIFOLS, S.A.: BUSINESS OVERVIEW
• FIGURE 52 GRIFOLS, S.A.: COMPANY SNAPSHOT (2022)
• 12.1.17 ANCHOR MOLECULAR
• TABLE 188 ANCHOR MOLECULAR: BUSINESS OVERVIEW
• 12.1.18 SPEEDX PTY. LTD.
• TABLE 189 SPEEDX PTY. LTD.: BUSINESS OVERVIEW
• 12.1.19 SEEGENE INC.
• TABLE 190 SEEGENE INC.: BUSINESS OVERVIEW
• FIGURE 53 SEEGENE INC: COMPANY SNAPSHOT (2022)
• 12.1.20 HELENA LABORATORIES CORPORATION
• TABLE 191 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
• 12.2 OTHER PLAYERS
  • 12.2.1 SERO AS
  • TABLE 192 SERO AS: BUSINESS OVERVIEW
  • 12.2.2 VIRCELL, S.L.
  • TABLE 193 VIRCELL, S.L.: BUSINESS OVERVIEW
  • 12.2.3 STRECK LLC
  • TABLE 194 STRECK LLC.: BUSINESS OVERVIEW
  • 12.2.4 SUN DIAGNOSTICS, LLC
  • TABLE 195 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
  • 12.2.5 MOLBIO DIAGNOSTICS PVT. LTD.
  • TABLE 196 MOLBIO DIAGNOSTICS PVT. LTD.: BUSINESS OVERVIEW
• *Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료